You are not tracking stonedinvestor.
30-Apr-08
SIMO NAILS IT! NEXT MNTA!
Folks remember to Watch My Watch List for the watched stocks are all additions I have made to my large account. As you can see we are doing quite well.
Today we buy MNTA.
Yup I'm backing up the old station wagon and loading up the MNTA today. There is PR release today getting NO LOVE THAT IS HUGE FOR THIS CO..... Read it, I'll post it in a bit... Not only that they were upgraded by Rodmin & Renshaw yesterday; not only that NotableCalls had a piece out this week on the name that I put in my Where We're At thread-
Morgan Stanley is upgrading Momenta Pharma (NASDAQ:MNTA) to Overweight-V and increasing their target to $22. Firm believes the stars could be finally aligning for the FDA approval of MNTA/NVS’s M-Enox in 2008-09 as the only genericversion of SNY’s Lovenox (blood thinner), potentially leading to: 1) 40-50% share of the $1.5+ billion U.S. Lovenox market, 2) peak potential earnings of $3/sh and 3) a share price of $40+. The downside risk of a long delay or non-approval is that the stock returns to $6.
Why are they upgrading now? Firm believes that the heparin (a complex sugar) contamination crisis may have given MNTA the unique opportunity to prove to the FDA its proprietary technology for characterizing complex sugars. Last week’s Nature publication shows that MNTA worked with the FDA to identify the heparin contaminant. They view this work as a game changer, underestimated by the Street. In our opinion, the FDA is now more likely to view MNTA’s technology as sufficient to show that M-Enox is the same as Lovenox (also a complex sugar) — a key regulatory hurdle and one they feel competitors Teva and Amphastar cannot achieve.
Notablecalls: This is a game-changing upgrade for this stock. Morgan Stanley has been neg on MNTA for quite some time (UW rating) and now they are saying the stock could do $35+ under bullish scenario.
The NC crew missed the fact that a news release further down shows MNTA announcing a presentation at.... of course Morgan. It's always hard to figure out the order of these things is the presentation set and then as luck would have it herceptin gets tainted or does the Co have a story to tell now... the fact that the co worked with the FDA in the emergency lends major creed to their case in my view. Perhaps sometime between today and the presentation Wed this could be bought for a nice hold. Big price target.
Ok Folks today we have new FDA news going into a speech today and a stk not reacting @$15.... opportunities like this is why I keep my nose to the grindstone every day. I bought this name lightly yesterday in anticipation of the analyst meeting at Morgan as well now we have an upgrade this news and another presentation on May FIVE..... This has some BIG possibilities a large super drug to be sure and a co that now seems to be on the same page with the FDA... this is a 1 year DOUBLE. Stoney PT. ~ $30.
Tagged Stocks: MNTA
Posted at 06:24 in External Blog | Permalink | Comments () | Top
Smallcap opportunit...
The down market is not all doom and gloom when you think abo...
christian
RRC
SELL RRC, Range Resources Corp. (NYSE) SHORT, RRC WILL DROP ...
joeserra
Good Price
It's been a while since it's been this cheap.
louisvuitton
Gas and oil from ju...
They manufacture a microwave machine that zaps junk to get g...
dreamerdave
Categories
Holding Tags
Watchlist Tags
Other Stock Tags
0 Comments on "SIMO NAILS IT! NEXT MNTA!"
You must be logged in to post a comment.
Top